| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/14/2000 | WO2000035430A3 Homer a new target of treating psychiatric disorders |
| 09/14/2000 | WO2000031263A3 Gtpase associated proteins |
| 09/14/2000 | WO2000030425A3 Method of using pon-1 to decrease atheroma formation |
| 09/14/2000 | WO2000026395A3 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors |
| 09/14/2000 | WO2000023603A3 Methods of treatment of type 2 diabetes |
| 09/14/2000 | DE19911039A1 Abgewandelte Aminosäureamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Modified amino acid amides, pharmaceutical compositions containing them and methods for their preparation |
| 09/14/2000 | CA2833396A1 Treatment of alpha-galactosidase a deficiency |
| 09/14/2000 | CA2366644A1 Tyrosine kinase inhibitors |
| 09/14/2000 | CA2366602A1 Pyridoxal analogues for vitamin b-6 disorders |
| 09/14/2000 | CA2366308A1 Inhibitors of protein tyrosine phosphatase |
| 09/14/2000 | CA2366281A1 Novel ligands of nuclear receptors ppar's |
| 09/14/2000 | CA2365869A1 Crystalline hydrated dihydroxy open-acid simvastatin calcium salt |
| 09/14/2000 | CA2365230A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions |
| 09/14/2000 | CA2364253A1 Dihydroxy open-acid and salts of hmg-co-a reductase inhibitors |
| 09/13/2000 | EP1034791A1 Anti-hypoxic and anti-ischemic drug |
| 09/13/2000 | EP1034786A1 Method for delivering direct feed microorganisms to poultry in ovo |
| 09/13/2000 | EP1034164A1 Substituted beta-alanine derivatives as cell adhesion inhibitors |
| 09/13/2000 | EP1033910A1 Dipeptide apoptosis inhibitors and the use thereof |
| 09/13/2000 | EP0975617A4 Inhibitors of cholesterol esterase |
| 09/13/2000 | EP0871611B1 New derivatives of glycylanilides, preparation and therapeutical application |
| 09/13/2000 | EP0764166B1 Corticotropin releasing factor antagonists |
| 09/13/2000 | CN1266371A Stable insulin formulations |
| 09/13/2000 | CN1265895A Specific medicine for treating common cold |
| 09/13/2000 | CN1056372C Thiazolidinedione derivatives, their production and use |
| 09/13/2000 | CN1056287C Traditional Chinese medicine for reducing blood-lipid and its preparation process |
| 09/12/2000 | US6117970 Sodium salt of [poly-(2,5-dihydroxyphenylene)]-4-thiosulphuric acid of linear structure as regulator of cell metabolism and production method thereof |
| 09/12/2000 | US6117912 Sublingual and buccal administration of selegiline for treating certain selegiline-responsive diseases and conditions |
| 09/12/2000 | US6117900 Use of retigabine for the treatment of neuropathic pain |
| 09/12/2000 | US6117899 Use of R-(+)-α-lipoic acid, R-(-)-dihydrolipoic acid and metabolites in the form of the free acid or as salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as its sequelae |
| 09/12/2000 | US6117893 Heterocyclic compounds having anti-diabetic activity and their use |
| 09/12/2000 | US6117861 Protein kinase C inhibitor |
| 09/12/2000 | US6117654 Nucleotide sequence coding antiinflammatroy proteins; antiarthritic agents; antiinflammatory agents; bronchodilator agents |
| 09/08/2000 | WO2000052051A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 09/08/2000 | WO2000052028A1 TUMOR NECROSIS FACTOR RECEPTORS 6α and 6$g(b) |
| 09/08/2000 | WO2000051997A1 Polycyclic thiazole systems and their utilization as anorectics |
| 09/08/2000 | WO2000051996A1 Polycyclic thiazole-2-ylides amines, method for the production thereof and their utilization as medicaments |
| 09/08/2000 | WO2000051994A1 Polycyclic 2-amino-dihydrothiazole systems, method for the production thereof and their utilization as medicament |
| 09/08/2000 | WO2000051987A2 Inhibitors of advanced, post-amadori glycosylation reactions |
| 09/08/2000 | WO2000051971A1 Oxamic acids and derivatives as thyroid receptor ligands |
| 09/08/2000 | WO2000051968A1 Method for the preparation of a chiral-beta-amino ester |
| 09/08/2000 | WO2000051686A1 Use of integrin antagonist and a chemotherapeutic agent in the treatment of neoplasia |
| 09/08/2000 | WO2000051628A2 Methods of modulating lipid metabolism and storage |
| 09/08/2000 | WO2000051602A1 Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity |
| 09/08/2000 | WO2000051594A1 Use of succinic acid or salts thereof and method of treating insulin resistance |
| 09/08/2000 | WO2000051444A1 Utilization of material containing docosapentaenoic acid |
| 09/08/2000 | WO2000037472A3 Substituted pirroloindoles |
| 09/08/2000 | WO2000029583A3 Immunoglobulin superfamily proteins |
| 09/08/2000 | WO2000027414A3 Inhibition of the formation of vascular hyperpermeability |
| 09/08/2000 | WO2000027341A3 Novel method of treatment |
| 09/08/2000 | WO2000019883A3 Compositions and methods of disease diagnosis and therapy |
| 09/08/2000 | WO2000012720A3 Elongase genes and uses thereof |
| 09/08/2000 | CA2366073A1 Use of succinic acid or salts thereof and method of treating insulin resistance |
| 09/08/2000 | CA2364903A1 Polycyclic thiazole systems and their utilization as anorectics |
| 09/08/2000 | CA2364902A1 Polycyclic thiazole-2-ylides amines, method for the production thereof and their utilization as medicaments |
| 09/08/2000 | CA2364899A1 Polycyclic 2-amino-dihydrothiazole systems, method for the production thereof and their utilization as medicament |
| 09/08/2000 | CA2362554A1 Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity |
| 09/08/2000 | CA2327260A1 Methods of modulating lipid metabolism and storage |
| 09/06/2000 | EP1033366A2 Amide derivatives useful as Neuropeptide Y (NPY) antagonists |
| 09/06/2000 | EP1033364A1 Cyano containing oxamic acids and derivatives as thyroid receptor ligands |
| 09/06/2000 | EP1033132A1 Rapidly soluble drug composition |
| 09/06/2000 | EP1033131A1 Composition of ingredients for a beverage having a delayed aversion effect |
| 09/06/2000 | EP1032682A1 Desaturase genes and their use |
| 09/06/2000 | EP1032667A2 A33-related antigens and their pharmacological uses |
| 09/06/2000 | EP1032587A1 Novel exendin agonist compounds |
| 09/06/2000 | EP1032575A1 2,3-diaryl-pyrazolo(1,5-b)pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors |
| 09/06/2000 | EP1032570A1 Isoquinoline derivatives and their therapeutical use |
| 09/06/2000 | EP1032424A1 Combination of an aldose reductase inhibitor and a glycogen phosphorylase inhibitor |
| 09/06/2000 | EP1032423A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
| 09/06/2000 | EP1032406A1 Reducing blood cholesterol by in vivo precipitation of bile constituents with group ii or -iii metal substances |
| 09/06/2000 | EP1032404A1 Use of sulfated oligosaccharides in lowering blood triglyceride levels |
| 09/06/2000 | EP1032403A1 Nutritional supplement for cerebral metabolic insufficiencies |
| 09/06/2000 | EP1032387A1 Novel metal complexes |
| 09/06/2000 | EP1032381A1 Naringin and naringenin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases |
| 09/06/2000 | EP0719145B1 Nitric oxide donor composition for treatment of anal disorders |
| 09/06/2000 | EP0568608B1 Fungal oil containing arachidonic acid, method for its preparation and composition containing said oil |
| 09/06/2000 | CN1265674A 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265670A Dipeptide and related compounds which inhibit leukocyte adhesion medicated by VLA-4 |
| 09/06/2000 | CN1265669A Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265657A Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265600A Cloning pigs using donor nuclei from differentiated cells |
| 09/06/2000 | CN1265584A Ascorbic acid-based formulation with improved colour stability |
| 09/06/2000 | CN1265564A Method for administering viable microorganism composition for poultry |
| 09/06/2000 | CN1265560A Composition and method for curing diabetes |
| 09/06/2000 | CN1056154C Method of producing reconstituted lipoproteins |
| 09/06/2000 | CN1056143C Piperidine derivatives and its use |
| 09/06/2000 | CN1056141C 哌嗪衍生物 Piperazine derivatives |
| 09/05/2000 | US6114599 Producing glucose regulated insulin producing cells whose proliferation is regulated by tetracycline; introducing into cells a tetracycline fusion protein gene, an insulin promoter and a gene encoding an sv40 antigen and tetracycline promoter |
| 09/05/2000 | US6114568 Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |
| 09/05/2000 | US6114545 Inhibitors of cholesterol esterase |
| 09/05/2000 | US6114517 Methods of modulating tumor necrosis factor α-induced expression of cell adhesion molecules |
| 09/05/2000 | US6114367 Such as 3-(3-cyclopentyloxy-4-methoxy)phenyl-2-isoxazoline-5-hydroxamic acid; treating sepsis, septic shock, inflammatory bowel disease, tuberculosis, graft versus host disease or cachexia associated with aids or cancer in a mammal |
| 09/05/2000 | US6114361 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives |
| 09/05/2000 | US6114328 Isoxazoline and isoxazole fibrogen receptor antagonists |
| 09/05/2000 | US6114322 Anticholesterol agent |
| 09/05/2000 | US6114317 Method of locking 1α-OH of vitamin D compounds in axial orientation |
| 09/05/2000 | US6114304 Administering an amylin agonist such as pramlintide or pramlintide acetate; reducing gastric motility or delaying gastric emptying |
| 09/05/2000 | US6114161 Isolated streptococcus sp pt strain dsm 8747 which produces a lipoteichoic acid used as an anticarcinogenic agent |
| 09/05/2000 | US6113949 Weight control product and method of treating hyperlipidemia and increasing vigor with said product |
| 09/05/2000 | US6113903 Antidiabetic agents |
| 09/05/2000 | US6113527 3,3-bis-hydroxymethyl-7-(cis-4-isopropyl-cyclohexyl)-1-phenyl -1,7-diaza-spiro-(3.5)nonane-2-one, for example; agonists of the orphanin fq (ofq) receptor; useful in the treatment of psychiatric, neurological and physiological disorders |